Clinical efficacy and safety: dermatologicals
The European Medicines Agency's scientific guidelines on the clinical evaluation of dermatologicals help medicine developers prepare marketing authorisation applications for human medicines.
If you have comments on a document which is open for consultation, use the .
Please submit your comments to the following email address: firstname.lastname@example.org.
For a complete list of scientific guidelines currently open for consultation, see Public consultations.